HONG KONG, July 28, 2023 (GLOBE NEWSWIRE) — CBL International Limited (Nasdaq: BANL) are thrilled to share with you a few milestones we have reached since the beginning of this year, which not only demonstrated CBL’s ability to ramp up its capacity but also our commitments to the sustainable development. In the second quarter of […]
Read MoreDay: July 28, 2023
LambdaTest announces the integration of its real devices platform with its test orchestration platform HyperExecute to enable blazing-fast mobile testing
Real Device Integration with HyperExecute allows businesses to seamlessly orchestrate and execute test scripts on a diverse range of real devices San Francisco , July 28, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform announced the launch of Real Device integration with HyperExecute, a continuous testing cloud solution that enables developers and […]
Read MoreArbor Metals to Assess Strategic Claims Adjacent to Its Jarnet Lithium Project in Quebec, Canada
Map of Arbor Metal Corp.’s Jarnet Lithium Claims VANCOUVER, British Columbia, July 28, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432) is pleased to announce that the Company has entered into an agreement to grant its technical team access to the data room of a strategically located set […]
Read MoreAKWEL: HALF-YEAR REVENUE UP +11.8%
Thursday 27 July 2023 HALF-YEAR REVENUE UP +11.8% AKWEL (FR0000053027, AKW, PEA-eligible), the automotive and HGV equipment and systems manufacturer specialising in fluid and mechanism management and structural parts for electric vehicles, posted consolidated revenue of €545.8m over the first half of 2023. Consolidated revenue In € millions – unaudited 2023 2022 Variation Like-for-like variation (1) […]
Read MoreOmico Brings Cutting Edge Technology Earlier in the Clinical Research Process
Omico Will Precisely Match Patients to George Clinical Oncology Trials SYDNEY, July 27, 2023 (GLOBE NEWSWIRE) — George Clinical recognises and applauds its collaborative partner Omico, with whom it is aligned in a common goal to revolutionize oncology clinical trial access for patients and improve the efficiency of study enrollment, on the launch of their […]
Read MoreNyxoah to Release Second Quarter 2023 Financial Results on August 8, 2023
Mont-Saint-Guibert, Belgium – July 27, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the second quarter of 2023 […]
Read More